EU commission chair speaks personally to vaccine company
On Monday afternoon, management at the biotech firm Curevac, based in Tübingen, Germany, took a call from no less than the chair of the EU commission herself, Ursula von der Leyen.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.